Drug recall · July 31, 2013
VIVITROL recall
Why: Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,
- Lots / codes
Individual vial lot 402-3683AA, EXP 10/13; kit vial lot 2011-003, EXP 08/13
- Quantity
- 3,325 vials
- Company
- Alkermes, Inc., Waltham, MA
- Distribution
- Nationwide
- Initiated
- November 6, 2012 · Voluntary: Firm initiated
- Classified
- July 24, 2013
- Reported
- July 31, 2013
- Ended
- August 28, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vivitrol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.